In this podcast Dr Elizabeth Whittaker, Dr James Seddon, Dr Pete Dodd and Professor Beate Kampmann discuss their work in pediatric tuberculosis focusing on the areas of immunology, modelling and drug resistance.
Browsing: Basic > Immunology
Researchers looking at the genome of M. tuberculosis have discovered that HIV co-infection could be influencing how the bacteria are evolving.
A Phase I clinical trial has demonstrated two investigational Ebola vaccines generate a durable immune response 1 year after vaccination.
New findings have identified the exact mechanism by which the bacterium Salmonella typhimurium can escape degradation by autophagy.
New study in mouse models suggests immune adaptation in pregnancy reduces the antiviral response allowing the influenza virus to mutate to more virulent strains and causing more severe infections.
Researchers have discovered a novel regulator of the innate immune response that may lead to the development of new antivirals and vaccines.
Researchers have utilized a novel mouse model to demonstrate that Zika infection during early pregnancy could lead to higher risk of miscarriage in addition to thin brain tissue and brain inflammation in infants.
Researchers have demonstrated that a specific subclass of antibody is elevated in patients who develop severe secondary dengue; this could lead to better identification of those at risk and possibly improved treatments and vaccines.
The most common cause of fungal meningitis for people with weak immune systems is Cryptococcus. This study aims to investigate the involvement of the autophagy protein 7 in the physiology and pathogenic potential of Cryptococcus neoformans.
Even in the era of antiretroviral treatment, mucosal candidiasis remains one of the most common manifestations in HIV-infected subjects. This editorial discusses the loss of immune control that allows mucosal candidiasis to occur.